Predictors and outcomes of extracorporeal membrane oxygenation in COVID-19 patients with ARDS: A propensity-matched analysis of national inpatient sample

Affiliations

Advocate Lutheran General Hospital

Abstract

Extracorporeal membrane oxygenation (ECMO) is a significant treatment modality for COVID-19 patients on ventilators. The current data is limited for understanding the indicators and outcomes of ECMO in COVID-19 patients with acute respiratory distress syndrome (ARDS). The National Inpatient Sample (NIS) database from 2020 was queried in this study. Among 1,666,960 patients admitted with COVID-19, 99,785 (5.98%) patients developed ARDS, and 60,114 (60.2%) were placed on mechanical ventilation. Of these mechanically ventilated COVID-ARDS patients, 2,580 (4.3%) were placed on ECMO. Patients with ECMO intervention had higher adjusted odds (aOR) of blood loss anemia (aOR 9.1, 95% CI: 6.16 - 13.5, propensity score-matched (PSM) 42% vs. 5.4%, P

Document Type

Article

PubMed ID

37473942


 

Share

COinS